drugset / Trial / NCT06713434
Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa
Phase 1
Active not recruiting
20 enrolled
Fundación DEBRA Chile, Niños Piel de Cristal
Centro de la Vision · collabEliksa Therapeutics, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
This study consists of two phases: an Observational Phase to evaluate the natural history of ocular manifestations in subjects with Dystrophic and Junctional Epidermolysis Bullosa, followed by a Treatment Phase to assess the effects of ELK-003 eye drops. Each subject will serve as their own control by comparing ocular manifestations documented during the Observational Phase to those recorded during the Treatment Phase.
Timeline
- Start
- 2024-05-07
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ELK-003 | Unknown | — | Topical |